ABL Bio Rises 7.82% Amid Dementia Theme Uptrend

On the 4th, the dementia theme rose by 3.02% compared to the previous day, showing strength, while ABL Bio, which is attracting attention as a related stock, surged by 7.82% compared to the previous day.

[Graph] Major Stocks’ Price Changes in the Dementia Theme



According to provisional data compiled at 11:58, foreigners and institutions are net buying 16,000 shares and 13,000 shares of ABL Bio, respectively.

[Table] Net Trading Volume by Foreigners and Institutions (Unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, ABL Bio’s quant financial score is 6.27 points, ranking 33rd in the dementia-related theme. This can be interpreted as ABL Bio having relatively low investment attractiveness from a financial perspective. On the other hand, Hwanin Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of the robo algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.